Literature DB >> 10963047

Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas.

T García-Caballero1, H M Mertani, A Lambert, R Gallego, M Fraga, E Pintos, J Forteza, M Chevallier, P E Lobie, B K Vonderhaar, A Beiras, G Morel.   

Abstract

The liver is an essential target tissue for growth hormone (GH) and prolactin (PRL). The aim of this study was to determine the in situ expression of growth hormone receptor (GHR) and prolactin receptor (PRLR) in hepatocellular carcinomas and to compare the results with normal liver. For this purpose, in situ hybridization (ISH) and immunohistochemical techniques were performed and several tests were conducted to validate the results. By radioactive ISH, all the hepatocellular carcinomas studied showed labeling for GHR and PRLR mRNAs. Relative expression levels, determined by computer-assisted microdensity, were higher in hepatocellular carcinomas than in normal liver. Immunohistochemistry led us to confirm the constant expression of both receptor proteins in hepatocellular carcinomas and normal liver and to demonstrate their localization not only in the cytoplasm but also in the nucleus. These results confirm that the liver is a major GH and PRL target tissue and suggest that in hepatocellular carcinomas the proliferative effects of these hormones may be increased by a higher expression of their receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963047     DOI: 10.1385/ENDO:12:3:265

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  46 in total

1.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Cellular expression of growth hormone and prolactin receptors in human breast disorders.

Authors:  H C Mertani; T Garcia-Caballero; A Lambert; F Gérard; C Palayer; J M Boutin; B K Vonderhaar; M J Waters; P E Lobie; G Morel
Journal:  Int J Cancer       Date:  1998-04-17       Impact factor: 7.396

3.  Characterization and subcellular distribution of somatogenic receptor in rat liver.

Authors:  B Husman; G Andersson; G Norstedt; J A Gustafsson
Journal:  Endocrinology       Date:  1985-06       Impact factor: 4.736

4.  Binding of growth hormone to rat liver during experimental chemical hepatocarcinogenesis.

Authors:  A Roitman; A Lev-Ran; B I Carr; D L Hwang; G Barseghian
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

5.  Absence of growth-hormone receptor in hepatocellular carcinoma and cirrhotic liver.

Authors:  T C Chang; J J Lin; S C Yu; T J Chang
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

6.  Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells.

Authors:  J M Boutin; M Edery; M Shirota; C Jolicoeur; L Lesueur; S Ali; D Gould; J Djiane; P A Kelly
Journal:  Mol Endocrinol       Date:  1989-09

7.  Immunocytochemical localization of prolactin receptors in rat liver cells: I. Dependence on sex and sex steroids.

Authors:  O V Smirnova; O M Petraschuk; P A Kelly
Journal:  Mol Cell Endocrinol       Date:  1994-10       Impact factor: 4.102

8.  Prolactin receptor immunoreactivity in rat anterior pituitary.

Authors:  G Morel; A Ouhtit; P A Kelly
Journal:  Neuroendocrinology       Date:  1994-01       Impact factor: 4.914

Review 9.  Regulation of growth hormone receptor gene expression.

Authors:  G Schwartzbauer; R K Menon
Journal:  Mol Genet Metab       Date:  1998-04       Impact factor: 4.797

10.  Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma.

Authors:  N Esposito; P Paterlini; P A Kelly; M C Postel-Vinay; J Finidori
Journal:  Mol Cell Endocrinol       Date:  1994-07       Impact factor: 4.102

View more
  22 in total

1.  Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs.

Authors:  Jennifer Mitchell; Peggy T Tinkey; Rony Avritscher; Carolyn Van Pelt; Ghazaleh Eskandari; Suraj Konnath George; Lianchun Xiao; Erik Cressman; Jeffrey S Morris; Asif Rashid; Ahmed O Kaseb; Hesham M Amin; Rajesh Uthamanthil
Journal:  Oncology       Date:  2016-06-16       Impact factor: 2.935

2.  A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer.

Authors:  Kathryn A O'Donnell; Vincent W Keng; Brian York; Erin L Reineke; Daekwan Seo; Danhua Fan; Kevin A T Silverstein; Christina T Schrum; Wei Rose Xie; Loris Mularoni; Sarah J Wheelan; Michael S Torbenson; Bert W O'Malley; David A Largaespada; Jef D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-03       Impact factor: 11.205

Review 3.  The growth hormone receptor: mechanism of activation and clinical implications.

Authors:  Andrew J Brooks; Michael J Waters
Journal:  Nat Rev Endocrinol       Date:  2010-07-27       Impact factor: 43.330

4.  Growth hormone receptor expression in human colorectal cancer.

Authors:  Xiaodong Yang; Fukun Liu; Zhe Xu; Che Chen; Gang Li; Xiaoyu Wu; Jieshou Li
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

5.  Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1.

Authors:  K S G Cunha; E P Barboza; E C Da Fonseca
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

Review 6.  Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

Authors:  Josué Barahona-Garrido; Jorge Hernández-Calleros; Ignacio García-Juárez; Jesús K Yamamoto-Furusho
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

7.  Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.

Authors:  Manal M Hassan; Ahmed Kaseb; Donghui Li; Yehuda Z Patt; Jean-Nicolas Vauthey; Melanie B Thomas; Steven A Curley; Margaret R Spitz; Steven I Sherman; Eddie K Abdalla; Marta Davila; Richard D Lozano; Deena M Hassan; Wenyaw Chan; Thomas D Brown; James L Abbruzzese
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis.

Authors:  Becky L Conway-Campbell; Jong Wei Wooh; Andrew J Brooks; David Gordon; Richard J Brown; Agnieszka M Lichanska; Hong Soon Chin; Chenoa L Barton; Glen M Boyle; Peter G Parsons; David A Jans; Michael J Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-09       Impact factor: 11.205

9.  Regulation of human growth hormone receptor expression by microRNAs.

Authors:  Samar Elzein; Cynthia Gates Goodyer
Journal:  Mol Endocrinol       Date:  2014-07-29

10.  Growth hormone receptor expression in human primary gastric adenocarcinoma.

Authors:  Xiaodong Yang; Ping Huang; Feng Wang; Zekuan Xu; Xiaonin Wang
Journal:  J Biomed Res       Date:  2012-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.